<%@ include view='MirrorPage' %>
Drug Discovery Today
AILSCI launch event
          WEBSITE           DIGITAL EDITION REGISTRATION           EVENTS           CONTACTS                                                          RSS   RSS feed

Drug Discovery Today ENews - April 2021

Editor's Choice

The Current issue of “The view from here” is concerned with Artificial Intelligence Please join us at the Zoom launch event for Elsevier’s new journal: “Artificial Intelligence in the Life Sciences” Wednesday May 5th 2021 at 3:00pm UK time. More


Free Research Articles to Download

Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
20 April 2021
Recent progress of machine learning to deep learning and the development of new algorithms answers the big data challenges.

Prefilled syringes East  Coast

Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet
20 April 2021
Data generation and analysis needs to move on from what can be done, to what should be done to arrive at safe and efficacious drugs faster and at lower cost.

Evolution May 2021

Artificial Intelligence in Drug Discovery and Development
20 April 2021
Artificial intelligence- integrated drug discovery and development has accelerated the growth of the pharmaceutical sector, leading to a revolutionary change in the pharma industry. Here, we discuss areas of integration, tools, and techniques utilized in enforcing AI, ongoing challenges, and ways to overcome them.

Injectable drug delivery

For a full list of downloads/ white papers, please visit

Industry News

Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials Company’s technologies and drug-hunting expertise now responsible for world’s first and second AI-designed drugs to enter Phase I testing More

Prefilled syringes West Coast

Healx partners with Ataxia UK and FARA to find treatments for Friedreich’s ataxia Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, announced that it would be working with Ataxia UK and FARA to develop novel treatments for Friedreich's ataxia - a rare neurodegenerative condition that causes issues with balance, speech and coordination. More

Pharma Micro WC 2021

Studying Shakespeare could help medical students connect with patients A palliative care doctor has suggested that studying Shakespeare’s plays could help medical students connect more closely with their patients. Writing in the Journal of the Royal Society of Medicine Dr David Jeffrey, of the Department of Palliative Medicine at the University of Edinburgh, investigates how the playwright’s empathic approach - the ability to understand and share the feelings of another - can enhance the patient-doctor relationship. More


The Pistoia Alliance Tackles Challenges in Data Governance to Advance Digital Transformation in Pharma Global not-for-profit launches a Data Governance Community of Interest to help companies improve data sharing infrastructure to accelerate R&D innovation More

Wearable Injectors 2021

Instant Covid Tests London to launch first test centre using 20-second Virolens technology The Medicines and Healthcare products Regulatory Agency (MHRA) has registered Virolens, which is now the fastest COVID-19 screening device in the country. Instant Covid Tests London’s (ICTL) test centre is based at The Brewery events space in the City of London, neighbouring thousands of workplaces. ICTL offers quick and effective testing solutions, offering businesses and individuals a fast-track back to normality More

Lab Innovation 2021

IONTAS and FairJourney Biologics enter antibody discovery agreement with Quell Therapeutics Diverse panel of novel target binders from IONTAS / FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline More

Ophthalmic Drugs 2021


For a full list of events and conferences, please visit

Subscribe to the Digital Edition

This message has been sent to <%= recipient.email %> from Elsevier Communications on behalf of Drug Discovery Today.

If you no longer wish to receive messages of this nature from us in the future, please <%@ include view='UnscubscriptionLink' %>.

Visit the <%@ include view='UnscubscriptionLinkSubscriptionLink' %> to manage your communication preferences with us.

Copyright © 2019 Elsevier B.V.. All rights reserved. | Elsevier Privacy Policy
Elsevier B.V. Registered Office: Radarweg 29, 1043 NX Amsterdam, The Netherlands. Reg. No. 33158992 – Netherlands. VAT No. NL 005033019B01.